In today’s global economy, intense competition, employee mobility, and the proliferation of spin-off and start-up businesses make the protection of trade secrets critical. Often the formulas, devices, techniques, patterns, processes, data compilations, and methods that companies use to bring breakthrough products to market are overlooked from an intellectual property (IP) perspective. Recent headlines confirm the threat of trade secret misappropriation by competitors and nation states, and reported verdicts and settlements in trade secrets misappropriation matters range in the hundreds of millions and even billions. These developments all demonstrate that trade secrets will remain a fundamental part of companies’ IP strategies.
Finnegan focuses its trade secret practice on matters involving complex technology. We have decades of experience counseling and advising on IP strategy in tech-heavy industries, and regularly litigate “bet the company cases.” Our deep bench of technical expertise, which includes 65+ professionals holding Ph.D.’s in disciplines ranging from neurobiology to electrical engineering, serves as a strong foundation to advise and litigate in specialized technology-related trade secret matters. We are able to efficiently and effectively work with engineers and scientists on unique trade secrets issues such as independent development, reverse engineering, and the state of the technical art.
Finnegan provides comprehensive trade secret protection and counseling to Fortune 500 and Global 1000 corporations, as well as innovative start-ups and organizations across all industries. Working closely with each client’s legal, business, and technical personnel, we help identify the key elements surrounding an innovation or technology that will benefit from trade secret protection. We also keep a watchful eye out for types of information that might warrant patent or copyright protection, or protection through various forms of confidentiality and noncompete agreements.
Trade secret investigations and cases often proceed on a fast track. From the moment a problem arises, speed is essential to prevent loss of the secret or to control the damage. This is where Finnegan brings a distinct advantage. We bring immediate and comprehensive legal and technical resources to each matter. If litigation is needed, our deep understanding of the technology allows us to devise persuasive and effective strategies, and to resolve the matter quickly.
When litigation becomes necessary to protect our clients’ trade secrets or to address a challenge from a competitor, our trial lawyers draw on decades of experience in federal and state courts. Trade secret litigation presents unique procedural challenges. We have a proven track record in addressing ex parte and preliminary injunctions, managing discovery, obtaining relief through dispositive motions, and preserving trade secrets during the course of litigation in trade secret actions.
Acted for an airport company in LCIA arbitration involving disclosures of confidential information.
Defended a global aerospace and defence company in an ICC arbitration claim on misappropriation of confidential information in breach of a non-disclosure agreement.
IL-2024-000026, UK High Court
Represented Rocket Pharmaceuticals, Inc. in district court litigation involving claims of trade secret misappropriation and breach of contract against corporate and individual defendants relating to complex treatments for genetic disorders. Obtained successful outcome including permanent injunction and other remedies against all defendants.
3:24-cv-02170, D. Or., Judge Simon
Represented Rocket Pharmaceuticals, Inc. in district court litigation involving claims of trade secret misappropriation and breach of contract against individual and corporate defendants and relating to complex treatments for genetic disorders. Successfully opposed motion to dismiss key claims and obtained settlement with all defendants following completion of fact discovery.
1:23-cv-09000, S.D.N.Y., Judges Castel, Aaron
Defending Accutar Biotechnology, Inc. in a trade secret lawsuit brought by Arvinas regarding alleged trade secrets concerning breast cancer therapies.
3:22-cv-00717, D. Conn., Judges Chatigny, Richardson
Webinar
Early Motions in Trade Secret Litigation – Offensive and Defensive Insights
July 15, 2026
Webinar
Federal Circuit IP Blog
Federal Circuit Holds Defend Trade Secrets Act Claim Untimely Filed
June 22, 2026
Commentary
BMW Uses Forum-Selection Clause to Shut Down ITC Trade Secret Investigation
July 31, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.